Showing results (651-660 of 672) with videos related to

Sort By:
Pageof 68
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2011
Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activationCollin L Ellis, Zhong-Min Ma, Surinder K Mann, et al.
AIDS (London, England)|November 26, 2019
Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapyTalia Sainz, Sergio Serrano-Villar, Surinder Mann, et al.
Plos Pathogens|May 4, 2017
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Plos Pathogens|January 23, 2016
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
The New England Journal of Medicine|December 12, 2003
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infectionGregory K Robbins, Victor De Gruttola, Robert W Shafer, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2006
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3Richard M Angell, Francis L Atkinson, Murray J Brown, et al.
Plos One|February 27, 2015
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W Tenforde, Nikhil Gupte, David W Dowdy, et al.
Molecular Biology of the Cell|January 30, 2016
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutationsGudio Veit, Radu G Avramescu, Annette N Chiang, et al.
Clinical Chemistry and Laboratory Medicine|April 12, 2023
Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest GroupsJulie L V Shaw, Saranya Arnoldo, Lori Beach, et al.
Nature Communications|March 16, 2022
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genesIndu Kohaar, Xijun Zhang, Shyh-Han Tan, et al.
Pageof 68